Cargando…
A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self‐renewal in human bladder cancer
Tumor recurrence is still a major challenge for clinical treatment of bladder cancer. Cumulative evidences indicate cancer stem cells (CSCs) contribute to drug resistance and leave a putative source for disease relapse. Identifying novel agents targeting CSCs may represent a new paradigm in the ther...
Autores principales: | Zhu, Lihong, Ni, Chen, Dong, Baijun, Zhang, Yong, Shi, Yuefeng, Niu, Haitao, Li, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055183/ https://www.ncbi.nlm.nih.gov/pubmed/27465044 http://dx.doi.org/10.1002/cam4.802 |
Ejemplares similares
-
Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
por: Kim, SungEun, et al.
Publicado: (2019) -
YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress
por: Qu, Si‐Yao, et al.
Publicado: (2017) -
Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020) -
lncRNA ABHD11‐AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2
por: Zeng, Xiang‐Yang, et al.
Publicado: (2019) -
BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells
por: Li, Feng, et al.
Publicado: (2019)